Subverted macrophages in the triple-negative breast cancer ecosystem

被引:6
作者
Shang, Linxiao [1 ]
Zhong, Yuting [2 ]
Yao, Yan [2 ]
Liu, Cun [3 ]
Wang, Lu [4 ]
Zhang, Wenfeng [5 ]
Liu, Jingyang [2 ]
Wang, Xue [4 ]
Sun, Changgang [6 ,7 ]
机构
[1] Binzhou Med Univ, Sch Integrated Tradit Chinese & Western Med, Yantai 264000, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250022, Peoples R China
[3] Weifang Med Univ, Coll Tradit Chinese Med, Weifang 261000, Peoples R China
[4] Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, Jinan 250022, Peoples R China
[5] Macau Univ Sci & Technol, Sch Tradit Chinese Med, Macau 999078, Peoples R China
[6] Weifang Tradit Chinese Hosp, Dept Oncol, Weifang 261000, Peoples R China
[7] Weifang Tradit Chinese Hosp, Dept Oncol, Weifang, Peoples R China
基金
中国国家自然科学基金;
关键词
Tumor -associated macrophage; Triple-negative breast cancer; Target; Immunosuppression; Subvert; TUMOR-ASSOCIATED MACROPHAGES; MONOCLONAL-ANTIBODY THERAPY; CHECKPOINT BLOCKADE; CELLS; MICROENVIRONMENT; POLARIZATION; RESISTANCE; RECEPTOR; NANOPARTICLES; PHAGOCYTOSIS;
D O I
10.1016/j.biopha.2023.115414
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tumor-associated macrophages (TAMs) are the most critical effector cells of innate immunity and the most abundant tumor-infiltrating immune cells. They play a key role in the clearance of apoptotic bodies, regulation of inflammation, and tissue repair to maintain homeostasis in vivo. With the progression of triple-negative breast cancer(TNBC), TAMs are "subverted" from tumor-promoting immune cells to tumor-promoting immune suppressor cells, which play a significant role in tumor development and are considered potential targets for cancer therapy. Here, we explored how macrophages, as the most important part of the TNBC ecosystem, are "subverted" to drive cancer evolution and the uniqueness of TAMs in TNBC progression and metastasis. Similarly, we discuss the rationale and available evidence for TAMs as potential targets for TNBC therapy.
引用
收藏
页数:14
相关论文
共 50 条
[31]   Clinical trials of immunotherapy in triple-negative breast cancer [J].
Howard, Frederick M. ;
Pearson, Alexander T. ;
Nanda, Rita .
BREAST CANCER RESEARCH AND TREATMENT, 2022, 195 (01) :1-15
[32]   Functional Proteomic Profiling of Triple-Negative Breast Cancer [J].
Gromova, Irina ;
Espinoza, Jaime A. ;
Grauslund, Morten ;
Santoni-Rugiu, Eric ;
Talman, Maj-Lis Moller ;
van Oostrum, Jan ;
Moreira, Jose M. A. .
CELLS, 2021, 10 (10)
[33]   Triple-negative breast cancer and the potential for targeted therapy [J].
Jhan, Jing-Ru ;
Andrechek, Eran R. .
PHARMACOGENOMICS, 2017, 18 (17) :1595-1609
[34]   Identification of dysregulated microRNAs in triple-negative breast cancer [J].
Yang, Fang ;
Zhang, Wenwen ;
Shen, Yan ;
Guan, Xiaoxiang .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (03) :927-932
[35]   Role of flavonoids in inhibiting triple-negative breast cancer [J].
Wang, Shuai ;
Wang, Kuanyu ;
Li, Cheng ;
Chen, Jing ;
Kong, Xiangding .
FRONTIERS IN PHARMACOLOGY, 2024, 15
[36]   Triple-negative breast cancer: current state of the art [J].
Rastelli, Francesca ;
Biancanelli, Sandra ;
Falzetta, Amalia ;
Martignetti, Angelo ;
Casi, Camilla ;
Bascioni, Romeo ;
Giustini, Lucio ;
Crispino, Sergio .
TUMORI JOURNAL, 2010, 96 (06) :875-888
[37]   Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes [J].
Kuroda, H. ;
Jamiyan, T. ;
Yamaguchi, R. ;
Kakumoto, A. ;
Abe, A. ;
Harada, O. ;
Masunaga, A. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (12) :2513-2525
[38]   High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis [J].
Yuan, Zhong-Yu ;
Luo, Rong-Zhen ;
Peng, Rou-Jun ;
Wang, Shu-Sen ;
Xue, Cong .
ONCOTARGETS AND THERAPY, 2014, 7 :1-6
[39]   Therapeutic delivery of siRNA for the management of breast cancer and triple-negative breast cancer [J].
Sai, Boya Manasa ;
Dinakar, Yirivinti Hayagreeva ;
Kumar, Hitesh ;
Jain, Rupshee ;
Kesharwani, Sharyu ;
Kesharwani, Siddharth S. ;
Mudavath, Shyam lal ;
Ramkishan, Ajmeer ;
Jain, Vikas .
THERAPEUTIC DELIVERY, 2024, 15 (11) :871-891
[40]   Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets [J].
Lv, Yan ;
Ma, Xiao ;
Du, Yuxin ;
Feng, Jifeng .
ONCOTARGETS AND THERAPY, 2021, 14 :589-607